Literature DB >> 16941653

Evidence of linkage and association on 18p11.2 for psychosis.

O Mukherjee1, P Meera, S Ghosh, S Kubendran, K Kiran, K R Manjunath, M N Subhash, V Benegal, S K Brahmachari, P P Majumder, S Jain.   

Abstract

The genetic basis of bipolar disorder (BPD) and schizophrenia (SCZ) has been established through numerous clinical and molecular studies. Although often considered separate nosological entities, evidence now suggests that the two syndromes may share some genetic liability. Recent studies have used a composite phenotype (psychosis) that includes BPD, SCZ, psychosis not otherwise specified, and schizoaffective disorder, to identify shared susceptibility loci. Several chromosomal regions are reported to be shared between these syndromes (18p, 6q, 10p, 13q, 22q). As a part of our endeavor to scan these regions, we report a positive linkage and association finding at 18p11.2 for psychosis. Two-point linkage analysis performed on a series of 52 multiplex pedigrees with 23 polymorphic markers yielded a LOD score of 2.02 at D18S37. An independent set of 159 parent offspring trios was used to confirm this suggestive finding. The TDT analysis yielded support for association between the marker D18S453 and the disease allele (chi2 = 4.829, P < 0.028). This region has been implicated by several studies on BPD [Sjoholt et al. (2004); Mol Psychiatry 9(6):621-629; Washizuka et al. (2004); Biol Psychiatry 56(7):483-489; Pickard et al. (2005); Psychiatr Genet 15(1):37-44], SCZ [Kikuchi et al. (2003); J Med Dent Sci 50(3):225-229; Babovic-Vuksanovic et al. (2004); Am J Med Genet 124(3):318-322] and also as a shared region between the two diseases [Ishiguro et al. (2001); J Neural Transm 108(7):849-854; Reyes et al. (2002); Mol Psychiatry 7(4):337-339; Craddock et al. (2005); J Med Genet 42(3):193-204]. Our findings provide an independent validation of the above reports, and suggest the presence of susceptibility loci for psychoses in this region. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16941653     DOI: 10.1002/ajmg.b.30363

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  Association between polymorphisms in the vesicle-associated membrane protein-associated protein A (VAPA) gene on chromosome 18p and bipolar disorder.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Wade H Berrettini
Journal:  J Neural Transm (Vienna)       Date:  2008-07-30       Impact factor: 3.575

2.  Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.

Authors:  Anne S Bassett; Christian R Marshall; Anath C Lionel; Eva W C Chow; Stephen W Scherer
Journal:  Hum Mol Genet       Date:  2008-09-20       Impact factor: 6.150

3.  Association between polymorphisms in the metallophosphoesterase (MPPE1) gene and bipolar disorder.

Authors:  Falk W Lohoff; Thomas N Ferraro; Edward S Brodkin; Andrew E Weller; Paul J Bloch
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

4.  A genome-wide linkage study of bipolar disorder and co-morbid migraine: replication of migraine linkage on chromosome 4q24, and suggestion of an overlapping susceptibility region for both disorders on chromosome 20p11.

Authors:  K J Oedegaard; T A Greenwood; A Lunde; O B Fasmer; H S Akiskal; J R Kelsoe
Journal:  J Affect Disord       Date:  2009-10-12       Impact factor: 4.839

5.  Molecular biology research in neuropsychiatry: India's contribution.

Authors:  T S Sathyanarayana Rao; B N Ramesh; P Vasudevaraju; K S J Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

6.  Chromosome 18p11.2 harbors susceptibility marker: D18S452, for bipolar affective disorder.

Authors:  Mutahar Andrabi; Arshad Hussain; Fouzia Rashid; Sheikh Ozair Nissar; Idrees Ayoub Shah; Yasir Hasan Rather; Waseem Hassan Ahangar; Nazir Ahmad Dar
Journal:  Indian J Psychiatry       Date:  2013-10       Impact factor: 1.759

7.  Genetic loci associated with an earlier age at onset in multiplex schizophrenia.

Authors:  Annemarie L Woolston; Po-Chang Hsiao; Po-Hsiu Kuo; Shi-Heng Wang; Yin-Ju Lien; Chih-Min Liu; Hai-Gwo Hwu; Tzu-Pin Lu; Eric Y Chuang; Li-Ching Chang; Chien-Hsiun Chen; Jer-Yuarn Wu; Ming T Tsuang; Wei J Chen
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

8.  A promoter polymorphism rs2075824 within IMPA2 gene affecting the transcription activity: possible relationship with schizophrenia.

Authors:  Jia Li; Sheng Huang; Hui-Rong Dai; Juan Wang; Li-Hui Lin; Hui Xiao; Xia Peng; Fei Li; Yu-Ping Wang; Jian-Min Yuan; Li Li
Journal:  J Cell Mol Med       Date:  2016-10-17       Impact factor: 5.310

9.  Nanoparticles: Is Toxicity a Concern?

Authors:  Ramakrishna D; Pragna Rao
Journal:  EJIFCC       Date:  2011-12-22

10.  Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes.

Authors:  Suhas Ganesh; Husayn Ahmed P; Ravi K Nadella; Ravi P More; Manasa Seshadri; Biju Viswanath; Mahendra Rao; Sanjeev Jain; Odity Mukherjee
Journal:  Psychiatry Clin Neurosci       Date:  2018-12-12       Impact factor: 5.188

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.